Bruce Myers, CFO of Pharmacopeia, will step down ”to pursue other opportunities” in May, following the company’s annual stockholders’ meeting. The Princeton, NJ-based parent company of Accelrys recently ended a dispute between key stockholders and company officials over the proposed acquisition of Eos Biotechnology, which stockholders ultimately voted against. It was not clear what role this played in Myers’ departure.